Results 101 to 110 of about 43,571 (190)
Navigating into the Chemical Space of Monoamine Oxidase Inhibitors by Artificial Intelligence and Cheminformatics Approach. [PDF]
Kumar S +7 more
europepmc +1 more source
Current treatment for Parkinson’s disease (PD) includes: levodopa, dopamine agonists, monoamine oxidase type B inhibitors, catechol-O-methyltransferase inhibitors, amantadine, anticholinergics, clozapine and deep brain stimulation. A lot of patients with
Yankov G., Ilieva V.
doaj +1 more source
Monoamine Oxidase Inhibitors: A Review of Their Anti-Inflammatory Therapeutic Potential and Mechanisms of Action. [PDF]
Ostadkarampour M, Putnins EE.
europepmc +1 more source
Chromenone Derivatives as Monoamine Oxidase Inhibitors from Marine-Derived MAR4 Clade Streptomyces sp. CNQ-031. [PDF]
Oh JM, Lee C, Nam SJ, Kim H.
europepmc +1 more source
Moving on With Monoamine Oxidase Inhibitors.
Bodkin JA, Dunlop BW.
europepmc +1 more source
The discovery of monoamine oxidase inhibitors: virtual screening and in vitro inhibition potencies. [PDF]
Shaw M +4 more
europepmc +1 more source
Benzylisoquinoline Biosynthesis by Cultivated Plant Cells and Isolated Enzymes [PDF]
Amann, Manfred +4 more
core +1 more source
Monoamine Oxidase Inhibitors in Toxic Models of Parkinsonism. [PDF]
Buneeva O, Medvedev A.
europepmc +1 more source

